Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00060931 · ClinicalTrials.gov registry record · Phase 4
Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension
A Phase 4 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 4
- Development phase
- 501
- Enrollment target
NCT00060931 is a Phase 4 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 501 participants.
The verdict
NCT00060931, a Phase 4 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 501 participants
- Enrollment target
Study Summary
Evaluation of the effect of two different antihypertensive treatments on control of glucose in Type II diabetic patients with high blood pressure
Interventions
- DRUG metoprolol
- DRUG carvedilol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 501 participants |
| Start Date | 2001-06 |
| Est. Completion | 2004-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00060931
The ClinicalTrials.gov registry entry for NCT00060931 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 501 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which metoprolol is the first listed.
NCT00060931 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00060931 about?
NCT00060931 is a clinical study titled "Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension". Evaluation of the effect of two different antihypertensive treatments on control of glucose in Type II diabetic patients with high blood pressure
What is the current status of trial NCT00060931?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 501 participants. The study started on 2001-06. Estimated completion is 2004-04.
What interventions are being tested in trial NCT00060931?
The interventions under investigation include: metoprolol (DRUG), carvedilol (DRUG).
Who is sponsoring clinical trial NCT00060931?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.